Trial intelligence / Profile preview

Experimental Stannous Fluoride Dentifrice for Gingival Health and Plaque Accumulation

NCT07255040Completed

Sponsor
Haleon
Start
Nov 2025
Primary completion
Jul 2026
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

Randomised, single-blind trial of stannous fluoride in gingivitis and dental plaque (3 arms), sponsored by Haleon. Primary endpoint: Number of Bleeding Sites (Overall) at Week 24. Started Nov 2025; status: completed.

02

Drugs

stannous fluoride
03

Conditions

gingivitisdental plaque

Beyond the preview

Go deeper on NCT07255040.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07255040.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call